Home/Filings/4/0001181431-10-023529
4//SEC Filing

CMEA VENTURES LIFE SCIENCES 2000 LP 4

Accession 0001181431-10-023529

CIK 0001200375other

Filed

Apr 28, 8:00 PM ET

Accepted

Apr 29, 9:41 PM ET

Size

46.2 KB

Accession

0001181431-10-023529

Insider Transaction Report

Form 4
Period: 2010-04-27
Transactions
  • Conversion

    Common Stock

    2010-04-27+1,418,4771,418,477 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+371,0432,740,158 total(indirect: See Footnote)
  • Conversion

    Series D Preferred Stock

    2010-04-2762,8150 total(indirect: See Footnote)
    Common Stock (62,815 underlying)
  • Conversion

    Series E Preferred Stock

    2010-04-2724,5250 total(indirect: See Footnote)
    Common Stock (24,525 underlying)
  • Conversion

    Series D Preferred Stock

    2010-04-27950,6380 total(indirect: See Footnote)
    Common Stock (950,638 underlying)
  • Other

    Warrant to Purchase Series D Preferred Stock

    2010-04-275,7300 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Series D Preferred Stock (5,730 underlying)
  • Other

    Warrant to Purchase Series D Preferred Stock

    2010-04-2786,7180 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Series D Preferred Stock (86,718 underlying)
  • Conversion

    Common Stock

    2010-04-27+93,72793,727 total(indirect: See Footnote)
  • Conversion

    Series B Preferred Stock

    2010-04-271,418,4770 total(indirect: See Footnote)
    Common Stock (1,418,477 underlying)
  • Conversion

    Common Stock

    2010-04-27+24,525181,067 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+950,6382,369,115 total(indirect: See Footnote)
  • Conversion

    Series B Preferred Stock

    2010-04-2793,7270 total(indirect: See Footnote)
    Common Stock (93,727 underlying)
  • Other

    Warrant to Purchase Common Stock

    2010-04-27+86,71886,718 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Common Stock (86,718 underlying)
  • Conversion

    Common Stock

    2010-04-27+62,815156,542 total(indirect: See Footnote)
  • Conversion

    Series E Preferred Stock

    2010-04-27371,0430 total(indirect: See Footnote)
    Common Stock (371,043 underlying)
  • Other

    Warrant to Purchase Common Stock

    2010-04-27+5,7305,730 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Common Stock (5,730 underlying)
Transactions
  • Conversion

    Series B Preferred Stock

    2010-04-2793,7270 total(indirect: See Footnote)
    Common Stock (93,727 underlying)
  • Conversion

    Common Stock

    2010-04-27+93,72793,727 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+24,525181,067 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+950,6382,369,115 total(indirect: See Footnote)
  • Conversion

    Series B Preferred Stock

    2010-04-271,418,4770 total(indirect: See Footnote)
    Common Stock (1,418,477 underlying)
  • Other

    Warrant to Purchase Series D Preferred Stock

    2010-04-275,7300 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Series D Preferred Stock (5,730 underlying)
  • Conversion

    Series D Preferred Stock

    2010-04-27950,6380 total(indirect: See Footnote)
    Common Stock (950,638 underlying)
  • Other

    Warrant to Purchase Common Stock

    2010-04-27+86,71886,718 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Common Stock (86,718 underlying)
  • Conversion

    Common Stock

    2010-04-27+62,815156,542 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+1,418,4771,418,477 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+371,0432,740,158 total(indirect: See Footnote)
  • Conversion

    Series D Preferred Stock

    2010-04-2762,8150 total(indirect: See Footnote)
    Common Stock (62,815 underlying)
  • Conversion

    Series E Preferred Stock

    2010-04-2724,5250 total(indirect: See Footnote)
    Common Stock (24,525 underlying)
  • Other

    Warrant to Purchase Common Stock

    2010-04-27+5,7305,730 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Common Stock (5,730 underlying)
  • Conversion

    Series E Preferred Stock

    2010-04-27371,0430 total(indirect: See Footnote)
    Common Stock (371,043 underlying)
  • Other

    Warrant to Purchase Series D Preferred Stock

    2010-04-2786,7180 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Series D Preferred Stock (86,718 underlying)
Transactions
  • Conversion

    Common Stock

    2010-04-27+24,525181,067 total(indirect: See Footnote)
  • Conversion

    Series E Preferred Stock

    2010-04-27371,0430 total(indirect: See Footnote)
    Common Stock (371,043 underlying)
  • Other

    Warrant to Purchase Common Stock

    2010-04-27+86,71886,718 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Common Stock (86,718 underlying)
  • Conversion

    Common Stock

    2010-04-27+1,418,4771,418,477 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+371,0432,740,158 total(indirect: See Footnote)
  • Conversion

    Series B Preferred Stock

    2010-04-271,418,4770 total(indirect: See Footnote)
    Common Stock (1,418,477 underlying)
  • Other

    Warrant to Purchase Common Stock

    2010-04-27+5,7305,730 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Common Stock (5,730 underlying)
  • Conversion

    Common Stock

    2010-04-27+93,72793,727 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+62,815156,542 total(indirect: See Footnote)
  • Conversion

    Series E Preferred Stock

    2010-04-2724,5250 total(indirect: See Footnote)
    Common Stock (24,525 underlying)
  • Other

    Warrant to Purchase Series D Preferred Stock

    2010-04-275,7300 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Series D Preferred Stock (5,730 underlying)
  • Other

    Warrant to Purchase Series D Preferred Stock

    2010-04-2786,7180 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Series D Preferred Stock (86,718 underlying)
  • Conversion

    Common Stock

    2010-04-27+950,6382,369,115 total(indirect: See Footnote)
  • Conversion

    Series B Preferred Stock

    2010-04-2793,7270 total(indirect: See Footnote)
    Common Stock (93,727 underlying)
  • Conversion

    Series D Preferred Stock

    2010-04-2762,8150 total(indirect: See Footnote)
    Common Stock (62,815 underlying)
  • Conversion

    Series D Preferred Stock

    2010-04-27950,6380 total(indirect: See Footnote)
    Common Stock (950,638 underlying)
Transactions
  • Conversion

    Series B Preferred Stock

    2010-04-2793,7270 total(indirect: See Footnote)
    Common Stock (93,727 underlying)
  • Conversion

    Series E Preferred Stock

    2010-04-27371,0430 total(indirect: See Footnote)
    Common Stock (371,043 underlying)
  • Conversion

    Common Stock

    2010-04-27+62,815156,542 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+950,6382,369,115 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+93,72793,727 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+24,525181,067 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+1,418,4771,418,477 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+371,0432,740,158 total(indirect: See Footnote)
  • Conversion

    Series D Preferred Stock

    2010-04-27950,6380 total(indirect: See Footnote)
    Common Stock (950,638 underlying)
  • Other

    Warrant to Purchase Common Stock

    2010-04-27+5,7305,730 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Common Stock (5,730 underlying)
  • Conversion

    Series D Preferred Stock

    2010-04-2762,8150 total(indirect: See Footnote)
    Common Stock (62,815 underlying)
  • Conversion

    Series B Preferred Stock

    2010-04-271,418,4770 total(indirect: See Footnote)
    Common Stock (1,418,477 underlying)
  • Other

    Warrant to Purchase Series D Preferred Stock

    2010-04-275,7300 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Series D Preferred Stock (5,730 underlying)
  • Other

    Warrant to Purchase Common Stock

    2010-04-27+86,71886,718 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Common Stock (86,718 underlying)
  • Conversion

    Series E Preferred Stock

    2010-04-2724,5250 total(indirect: See Footnote)
    Common Stock (24,525 underlying)
  • Other

    Warrant to Purchase Series D Preferred Stock

    2010-04-2786,7180 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Series D Preferred Stock (86,718 underlying)
Transactions
  • Conversion

    Common Stock

    2010-04-27+93,72793,727 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+24,525181,067 total(indirect: See Footnote)
  • Conversion

    Series D Preferred Stock

    2010-04-2762,8150 total(indirect: See Footnote)
    Common Stock (62,815 underlying)
  • Conversion

    Series B Preferred Stock

    2010-04-271,418,4770 total(indirect: See Footnote)
    Common Stock (1,418,477 underlying)
  • Conversion

    Series E Preferred Stock

    2010-04-27371,0430 total(indirect: See Footnote)
    Common Stock (371,043 underlying)
  • Other

    Warrant to Purchase Series D Preferred Stock

    2010-04-2786,7180 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Series D Preferred Stock (86,718 underlying)
  • Conversion

    Common Stock

    2010-04-27+950,6382,369,115 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+371,0432,740,158 total(indirect: See Footnote)
  • Conversion

    Series B Preferred Stock

    2010-04-2793,7270 total(indirect: See Footnote)
    Common Stock (93,727 underlying)
  • Conversion

    Series E Preferred Stock

    2010-04-2724,5250 total(indirect: See Footnote)
    Common Stock (24,525 underlying)
  • Conversion

    Series D Preferred Stock

    2010-04-27950,6380 total(indirect: See Footnote)
    Common Stock (950,638 underlying)
  • Other

    Warrant to Purchase Common Stock

    2010-04-27+5,7305,730 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Common Stock (5,730 underlying)
  • Conversion

    Common Stock

    2010-04-27+62,815156,542 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2010-04-27+1,418,4771,418,477 total(indirect: See Footnote)
  • Other

    Warrant to Purchase Series D Preferred Stock

    2010-04-275,7300 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Series D Preferred Stock (5,730 underlying)
  • Other

    Warrant to Purchase Common Stock

    2010-04-27+86,71886,718 total(indirect: See Footnote)
    Exercise: $5.96Exp: 2013-05-25Common Stock (86,718 underlying)
Footnotes (9)
  • [F1]Reflects a 2-for-3 reverse stock split of the Issuer's outstanding securities effected immediately prior to the effectiveness of the Issuer's S-1 Registration Statement (Commission File No. 333-164044).
  • [F2]Each share of Series B Preferred Stock automatically converted into Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering.
  • [F3]Held by CMEA Ventures Life Sciences 2000, Civil Law Partnership. Thomas R. Baruch, a member of the Issuer's board of directors, David Collier and Karl Handelsman are general partners of CMEA Ventures LS Management 2000, L.P., the managing limited partner of CMEA Ventures Life Sciences 2000, Civil Law Partnership, and, as such, have voting and investment power over the securities held by CMEA Ventures Life Sciences 2000, Civil Law Partnership. Each of the Reporting Persons disclaims beneficial ownership of the securities reported in this Form 4 except to the extent of any pecuniary interest therein.
  • [F4]Each share of Series D Preferred Stock automatically converted into Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering.
  • [F5]As previously reported on the Form 3 dated April 21, 2010, due to the antidilution provisions of the Issuer's certificate of incorporation that apply to the Series E Preferred Stock, each share of Series E Preferred Stock automatically converted into Common Stock on a 1.008702-for-1 basis upon the closing of the Issuer's initial public offering. Number of shares reported includes the additional 211 shares and 3,200 shares of Common Stock that was issued to CMEA Ventures Life Sciences 2000, Civil Law Partnership and CMEA Ventures Life Sciences 2000, L.P., respectively, upon such conversion as a result of such antidilution adjustment.
  • [F6]Held by CMEA Ventures Life Sciences 2000, L.P. Thomas R. Baruch, a member of the Issuer's board of directors, David Collier and Karl Handelsman are general partners of CMEA Ventures LS Management 2000, L.P., the general partner of CMEA Ventures Life Sciences 2000, L.P., and, as such, have voting and investment power over the securities held by CMEA Ventures Life Sciences 2000, L.P. Each of the Reporting Persons disclaims beneficial ownership of the securities reported in this Form 4 except to the extent of any pecuniary interest therein.
  • [F7]The expiration date is not relevant to the conversion of these securities.
  • [F8]Upon completion of the Issuer's initial public offering, the warrant to purchase shares of Series D Preferred Stock automatically converted into a warrant to purchase an equal number of shares of the Issuer's Common Stock. Disposition of Warrant to Series D Preferred Stock and acquisition of Warrant to Purchase Common Stock listed solely for the purpose of reporting such conversion of the shares underlying the security.
  • [F9]This warrant is immediately exercisable.

Issuer

CODEXIS INC

CIK 0001200375

Entity typeother

Related Parties

1
  • filerCIK 0001127950

Filing Metadata

Form type
4
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 9:41 PM ET
Size
46.2 KB